SEASONAL AFFECTIVE DISORDER MARKET ANALYSIS

Seasonal Affective Disorder Market, by Type (Fall & Winter Seasonal Affective Disorder, Spring & Summer Seasonal Affective Disorder, and Others), by Treatment (Light Therapy, Medications, Psychotherapy, Counselling, and Others), by End User (Hospitals, Clinics, Research Institutes, and Others), and by Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa) - Size, Share, Outlook, and Opportunity Analysis, 2020 - 2027

Published In : Dec 2020
Code : CMI4333
Pages :195
Formats :
Excel and PDF
Industry : Pharmaceutical

Market Challenges And Opportunities

However, side effects of seasonal affective disorder medication such as Bupropion is expected to hinder the market growth. For instance, according to an article published by the National Center for Biotechnology Information (NCBI), in October 2020, reports that the drug Bupropion, which is approved by the U.S. FDA exhibit several side effects such as ophthalmologic including blurred vision; central nervous system including insomnia, headache, agitation, dizziness; dermatologic such as diaphoresis, and others.